Euan Thomson - Carl Zeiss Pres Unit
| CZMWY Stock | USD 59.54 0.27 0.45% |
Insider
Euan Thomson is Pres Unit of Carl Zeiss Meditec
| Age | 60 |
| Phone | 49 3641 220 115 |
| Web | https://www.zeiss.de/meditec-ag/home.html |
Euan Thomson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Euan Thomson against Carl Zeiss pink sheet is an integral part of due diligence when investing in Carl Zeiss. Euan Thomson insider activity provides valuable insight into whether Carl Zeiss is net buyers or sellers over its current business cycle. Note, Carl Zeiss insiders must abide by specific rules, including filing SEC forms every time they buy or sell Carl Zeiss'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Euan Thomson over a year ago Acquisition by Euan Thomson of 10000 shares of Stereotaxis subject to Rule 16b-3 |
Carl Zeiss Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1596 %, meaning that it generated $0.1596 on every $100 dollars invested by stockholders. Carl Zeiss' management efficiency ratios could be used to measure how well Carl Zeiss manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | INSIDER Age | ||
| Augustine JD | Hoya Corp | 55 | |
| Kensuke Lizuka | Sysmex Corp | N/A | |
| Tomoko Nakagawa | Hoya Corp | N/A | |
| Richard Rosenzweig | AngioDynamics | 57 | |
| Taishi Arashida | Hoya Corp | N/A | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0955 |
Carl Zeiss Meditec Leadership Team
Elected by the shareholders, the Carl Zeiss' board of directors comprises two types of representatives: Carl Zeiss inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carl. The board's role is to monitor Carl Zeiss' management team and ensure that shareholders' interests are well served. Carl Zeiss' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carl Zeiss' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sebastian Frericks, Director Investor Relations | ||
| Laurie Ferguson, Head Devices | ||
| Markus Weber, CEO Pres | ||
| Martin Wiechmann, Head Unit | ||
| Andrew Chang, I Meditec | ||
| Euan Thomson, Pres Unit | ||
| Steven MD, Chief Devices | ||
| Justus Wehmer, CFO, Member of the Management Board | ||
| Mike Wang, Head Shanghai |
Carl Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Carl Zeiss a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 12.07 B | |||
| Shares Outstanding | 89.44 M | |||
| Price To Earning | 78.84 X | |||
| Price To Book | 6.64 X | |||
| Price To Sales | 6.17 X | |||
| Revenue | 1.9 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Carl Pink Sheet Analysis
When running Carl Zeiss' price analysis, check to measure Carl Zeiss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carl Zeiss is operating at the current time. Most of Carl Zeiss' value examination focuses on studying past and present price action to predict the probability of Carl Zeiss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carl Zeiss' price. Additionally, you may evaluate how the addition of Carl Zeiss to your portfolios can decrease your overall portfolio volatility.